SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?
Por um escritor misterioso
Descrição
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA
PDF) Does mismatch negativity have utility for NMDA receptor drug
PDF) Does mismatch negativity have utility for NMDA receptor drug
Targeting NMDA receptors in neuropsychiatric disorders by drug
PDF) Neuroprogression in schizophrenia: Pathways underpinning
IJMS, Free Full-Text
Delivering medicines for depression and central nervous system
SciELO - Brazil - Does mismatch negativity have utility for NMDA
NMDAR-dependent long-term depression is associated with increased
Summary of the mechanisms of how N-methyl-D-aspartate receptor
Teste 2nd by Second Digital - Issuu
Ketamine and Other NMDA Antagonists: Early Clinical Trials and
NMDA Antagonists and Their Role in the Management of Bipolar
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain
N-Methyl D-aspartate receptor subunit signaling in fear extinction
de
por adulto (o preço varia de acordo com o tamanho do grupo)
